Japan becomes first country to approve Ronapreve for COVID-19
Roche announced that Japans Ministry of Health, Labour and Welfare has approved Ronapreve casirivimab and imdevimab, for the treatment of patients with mild to moderate COVID-19 via intravenous infusion. The antibody combination was granted a Special Approval Pathway under article 14-3 of the Pharmaceuticals and Medical Devices Act.